Difference between revisions of "Template talk:Next oroboros ecosystem agenda"
Line 79: | Line 79: | ||
=== Next === | === Next === | ||
*'''Mar-31 We''' Ā | *'''Mar-31 We''' Ā | ||
Line 136: | Line 129: | ||
Ā | |||
=== Removed for correction === | === Removed for correction === |
Revision as of 16:46, 18 March 2021
- Antunes Diana (talk) 08:58, 5 May 2020 (CEST) Format for new Agenda/Alerts entries:
{| | logos | title in bold <br> - link |}
e.g.,
Did you know that the proper use of TIP2k-Filter Papers may avoid an unstable O2 slope neg. signal during Instrumental background correction?
- Ā»Instrumental backgroundĀ« and Ā»TIP2k Filter PapersĀ«
- See the scheme:
Bioblast alert 2021
Prep for circular:
MitoPedia alert
Next
O2k-Brief alert
Next
O2k-Publications alert
Author names of O2k-Publications/ Brief for the Agenda vs Bioblast
- 1.Oroboros Ecosystem Agenda: SOP: Surname with long version and First name with short version. Please, see: Template alerts.
- Example: Oroboros Ecosystem Agenda example
- This means that we have to edit manually the author names within the O2k-Publications/ Brief alerts (i.e., Antunes Diana (from Bioblast) to Antunes D (to Agenda entries)) if they are long or copy from the gray box.
- 2.Bioblast: SOP: [1] ā examples are available using both Surname and First name with long version (e.g., Antunes Diana). If in Bioblast the authors are with short surname in the links please update it to complete surname, guidelines are below.
- 1.Oroboros Ecosystem Agenda: SOP: Surname with long version and First name with short version. Please, see: Template alerts.
Guidelines to update a reference
- When creating an O2k-Publication/Brief alert, it is the responsibility of the author to check if the reference is accordingly to the correct guidelines:
- Correct format for a person called āFirst Name Surnameā:
- In the gray box should be āSurname FNā - From where references to be used as O2k-Publication/Brief alerts are copied from.
- In the links should be ā Surname First Nā
- How to edit:
- A) Check if all authors with profiles in Bioblast (blue links) have their profiles with full name. If they have, proceed to next step (B). If not, you need to move it following the steps āHow to move a profileā below.
- B) Click in āEdit with formā.
- C) The gray box is edited in āReferenceā and the links are changed in āAuthor(s)ā. Change it accordingly and click in āsave pageā at the end of the page.
- How to edit:
How to move a profile (instructions sent by Marija):
So letās take for example my page: Beno M [2]
- As you can see there is a redirect from Beno Marija to Beno M. What has to be done is to switch the content of those pages. Here are the steps:
- 1. Go to e.g. āBeno Mā on edit
- 2. Click on āMoveā
- 3. Change the new title to the full name of the person. In my case it will be Beno M to Beno Marija
- As you can see there is a redirect from Beno Marija to Beno M. What has to be done is to switch the content of those pages. Here are the steps:
- 4. Now it should look like that:
- 5. Click on āMoveā and leave all the ticked boxes
- 6.Done
- After that you can continue in step B.
- If you have any doubt you can contact Cristiane, Marija or Mario.
Next
- Mar-31 We
Mitochondria-targeted iron chelator deferoxamine is a promising anti-cancer drug by inducing mitochondrial dysfunction and mitophagy
- from the O2k-Network Ā»AU Queensland Neuzil JĀ« and Ā»CZ Prague Neuzil JĀ«
- Sandoval-AcuƱa C, Torrealba N, Tomkova V, Jadhav SB, Blazkova K, Merta L, Lettlova S, AdamcovĆ” MK, Rosel D, BrĆ”bek J, Neuzil J, Stursa J, Werner L, Truksa J (2021) Targeting mitochondrial iron metabolism suppresses tumor growth and metastasis by inducing mitochondrial dysfunction and mitophagy. Cancer Res [Epub ahead of print].Ā»Bioblast linkĀ«
O2k-Open Support alert
- While in Home Office: Gnaigere (talk) 14:03, 19 March 2020 (CET) https://wiki.oroboros.at/index.php/Talk:O2k-Open_Support_alert - Many labs will move to home office mode. In line with our special DL7.4 home office offer (see Agenda today), therefore, I suggest to post in our Agenda analysis-linked O2k-Open Support cases during this time, and collect real-time operation cases for future releases.
Next
Do you know what to do when the fluorescence signal starts at a negative value?
A high signal may be caused by wet Fluo-Sensors. For further information:
- Ā»Negative fluorescence signalĀ«
Abnormal fluorescence signal?
Follow these steps to localize and solve the problem:
- Ā»Noisy fluorescence signalĀ«
Why is the fluorescence signal constantly at 10 V or at 0 V?
Follow these steps to localize and solve the problem:
- Ā»Fluorescence signal is constantly at 10 VĀ« and Ā»Zero fluorescence signalĀ«
What is the advantage of using flux control ratios (FCRs)?
FCRs provide information on coupling and substrate control of mitochondrial respiration independent of (i) mt-content in cells or tissues, (ii) purification of isolated mitochondrial preparations, and (iii) assay conditions for determination of tissue mass or mt-markers.
- Ā»Flux control ratioĀ«
Under discussion
Removed for correction
- Nov-30 Mo
Noisy oxygen signal? Check the OroboPOS and OroboPOS-Connector to clean electrical connections.
Contaminating grease, salt crystals and moisture can be removed with a dry paper cloth or a paper cloth moistened with water and then absolute ethanol.
- Ā»Cleaning the electrical connectionsĀ«
- communicated by Ā»Schmitt SabineĀ« and Ā»Komlodi TimeaĀ«
WGT recommended not to use water for cleaning. Erich introduced water for cleaning to remove salt crystals.
Do you perform the leaky chamber test after chamber assembly?
An unnoticed leak from the chamber may affect your data, therefore we recommend performing the Leaky chamber test - especially after chamber reassembly.
- Ā»Leaky chamber testĀ« and Ā» https://intern.oroboros.at/index.php/Overnight_test_after_O2k-chamber_assemblyĀ«
O2k-Open Support alert circulars
In preparation
For discussion
Here we discuss suggestions for the Oroboros Ecosystem Agenda 2020 (if the specific alert section is yet to be attributed)
Controlled stability of the MitoKit-CII based on HPLC and LCMS analysis: No degradation of MitoKit-CII compounds MitoKit-CII/Succinate-nv (NV118) and MitoKit-CII/Malonate-nv (NV161) for following storage conditions: - Proven -80 Ā°C solid stability for more than 3 years (3 years 7 months)
- Proven -20 Ā°C solid stability for 1 year
- Proven DMSO stability at room temperature for 1 week
- Proven DMSO stability at -20 Ā°C for 6 months (ongoing)
2021
- 2021-01-06 https://www.jstor.org/stable/1706346?seq=1
Postponed events
- Pre-Conference O2k-Workshop Ā»MiPNet25.11 IOC148 Riga LV Ā« March 2021?
- Ā»6th EU-Cardioprotection Meeting 2020 Riga LVĀ« (Oct 7-9)- March 2021?
- Ā»APS2020 Chicago USĀ«
- Abstracts deadline 10th Int. CeBiTec Research Conference Advances in Industrial Biotechnology: Prospects and challenges for the development of algal biotechnology
- Notification to oral and poster presenters - Ā»MitoEAGLE Summit Obergurgl 2020Ā« (2020 Nov 04-07) and Ā»MiPschool Obergurgl 2020Ā« (2020 Nov 09-11)
- Bioenergetics Vienna 2020
- IOC Schroecken AT
- Registration and late Abstract Deadline - Ā»MitoEAGLE Summit Obergurgl 2020Ā« and Ā»MiPschool Obergurgl 2020Ā«
- Ā»36th Congress Czech Nutrition Society 2020 Hradec Kralove CZĀ« (Sep 10-12)